Skip to content
Home
Journalists
Headlines
Community
Businesses
Jobs
Learning
Marketplace
Store
(@)
Novo Nordisk sinks after its experimental obesity drug falls short of Eli Lilly’s in head-to-head trial
Earlier this month, Novo predicted that its sales would decline by between 5% and 13% in 2026 amid rising competition.
Author:
J. Edward Moreno
Written by
J. Edward Moreno
in
Business
←
East Coast Blizzard Forces Nationwide Cancellations and Delays
Notorious Mexican Drug Lord Killed, Igniting a Wave of Violence
→
More posts
Pure Joy: Photographer Laylah Amatullah Barrayn Captures Her First ESSENCE Festival Of Culture
Angry crowd confronts Republican Rep. Mike Flood at Nebraska town hall
Rhea Seehorn celebrates her ‘Pluribus’ Emmy nomination as she waits to hear about Carol and the atom bomb
Emmy Nominations Analysis: ‘The Pitt’ And ‘Hacks’ Dominance Proves It Helps To Be On A Show Voters Actually Watch
